Keyphrases
Randomized Placebo-controlled Trial
100%
Gut Microbiota
100%
Azithromycin
100%
Placebo
57%
Fecal Samples
28%
Gut Microbiota Composition
28%
Asthma Symptoms
14%
Capital Region
14%
Clinical Benefit
14%
Shannon Diversity Index
14%
Respiratory Infection
14%
Asthma
14%
Oral Solution
14%
16S rRNA Gene Amplicon Sequencing
14%
Ministry of Health
14%
Bifidobacterium
14%
Young children
14%
Episode Duration
14%
Strategic Research
14%
Lundbeck
14%
Acute Asthma
14%
Actinobacteria
14%
Long-lasting Effect
14%
China
14%
Therapeutic Use
14%
Macrolides
14%
Microbial Composition
14%
Medicine and Dentistry
Azithromycin
100%
Gut Microbiota
100%
Placebo
100%
Asthma
42%
Lomustine
14%
Therapeutic Use
14%
Respiratory Tract Infection
14%
RNA 16S
14%
Amplicon Sequencing
14%
Side Effect
14%
Macrolide
14%
Bifidobacterium
14%
Toddlers
14%
Actinobacteria
14%
Pharmacology, Toxicology and Pharmaceutical Science
Intestine Flora
100%
Azithromycin
100%
Placebo
100%
Asthma
42%
RNA 16S
14%
Bifidobacterium
14%
Microflora
14%
Therapeutic Use
14%
Respiratory Tract Infection
14%
Side Effect
14%
Lomustine
14%
Macrolide
14%
Actinobacteria
14%
Immunology and Microbiology
Intestine Flora
100%
Asthma
50%
Actinobacteria
16%
Bifidobacterium
16%
Phylum
16%
Solution and Solubility
16%
RNA Gene
16%
Microflora
16%
Amplicon Sequencing
16%